| K-number | K191324 |
| Device name | CivaDerm |
| Applicant | Civatech Oncology, Inc. |
| Product code | KXK |
| Device class | Class II |
| Decision date | Sep 20, 2019 |
| Decision | Substantially Equivalent |
| Regulation | 892.5730 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov